sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Press ReleaseFood & Beverages

Meat Glue Market Set for 7.5% Growth to USD 1065 million by 2034

41.98% of 2025 revenue sits in Asia Pacific, and 10.75% growth in Plant leads the type axis.

PUNE, INDIA — 21 SEPTEMBER 2026CONTRIVE DATUM INSIGHTS

Market reaches USD 1065 million by 2034, up from USD 555 million in 2025, at a 7.5% CAGR.

Asia Pacific holds 41.98% of 2025 revenue at USD 233 million.

Plant is the fastest-growing line at 10.75% annually.

90.99% of 2025 revenue sits in Microbial, the largest type line.

Contrive Datum Insights has published "Meat Glue Market Size, Share & Industry Analysis, By Type (Animal, Plant, Microbial), Application (Fish, Processed food, Dairy, Bakery Products), Form (Powder, Liquid/Solution), End user (Industrial Food Processors, Foodservice/Culinary, Retail/Household), Distribution channel (Direct/B2B Sales, Distributors & Wholesalers), and Regional Forecast, 2026-2034". The study sizes the global meat glue market at USD 555 million in 2025 and projects growth from USD 597 million in 2026 to USD 1065 million by 2034, a compound annual growth rate of 7.5% across the forecast period.

Meat glue is an enzyme preparation, most commonly transglutaminase, that binds separate cuts of meat, fish or other protein together into a single, cohesive piece instead of holding them with a physical binder. Industrial meat, poultry and seafood processors use it to produce reformed steaks, restructured deli portions and surimi-based products, and smaller volumes reach bakery and dairy manufacturers seeking to modify texture. Buyers range from large-scale food processors under supply contracts to foodservice operators and specialty retailers serving butchers and home cooks in small pack sizes.

Rising restructured and processed meat and poultry consumption, led by Asia Pacific

Rising restructured and processed meat and poultry consumption, led by Asia Pacific is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 7.5% a year, the type lines exposed to it move fastest: Plant compounds at 10.75%, taking its share of revenue from 3.06% to 4.04% and its value from USD 17 million to USD 43 million.

Where the forecast could be beaten: the bull case assumes faster regulatory approval of plant-derived and microbial transglutaminase across additional export markets, letting processors convert to lower-cost formulations sooner and expanding total enzyme volume faster than the base case. The study puts that case at USD 1182 million in 2034, against USD 1065 million in the base.

The downside is specific. The bear case assumes tighter labeling and disclosure requirements for restructured meat products in a major consuming market, slowing processor adoption and enzyme volume growth relative to the base case, and 2034 revenue lands at USD 948 million. Animal is the drag, 5.95% of the 2025 base compounding at -0.75% while the market runs at 7.5%.

Where the Competition Actually Sits

The type axis, not the regional one, is what divides the field. Microbial is the volume position, 90.99% of 2025 revenue at USD 505 million, holding 92.96% through 2034, and it is defended by scale. Plant is the growth position at 10.75%, and it is open. Strength in one does not carry into the other.

Additional Findings

SegmentLed 2025 byShare & valueFastest-growing
ApplicationProcessed food58.02% · USD 322 millionBakery Products 11.4%
FormPowder81.98% · USD 455 millionLiquid/Solution 9.91%
End userIndustrial Food Processors87.93% · USD 488 millionRetail/Household 10.57%
Distribution channelDirect/B2B Sales70.99% · USD 394 millionDistributors & Wholesalers 8.7%
  • Asia Pacific was the largest region in 2025, holding 41.98% of global revenue at USD 233 million and reaching USD 469 million by 2034.
  • Asia Pacific takes a rising share of global revenue over the forecast period, from 41.98% in 2025 to 44.04% in 2034, with revenue growing from USD 233 million to USD 469 million.
  • Middle East and Africa stays the smallest contributor across the period: 6.13% of revenue in 2025 and 6.95% in 2034.
  • By type, the largest line in 2025 was Microbial, at 90.99% of revenue and USD 505 million.
  • The fastest type line is Plant, forecast to compound at 10.75% through the period.
  • China is the largest single country market at USD 105 million in 2025, 18.92% of global revenue.

Every year from 2020 to 2034 is reported, with revenue and growth for each line across five axes: by type, and by application, form, end user and distribution channel. The headline total carries bear, base and bull cases at USD 948 million and USD 1182 million by 2034. The study also breaks out all five regions to country level, sets out the competitive landscape, and documents the method behind every estimate. Available as a PDF, with a free sample on request.

Regions Covered
Asia PacificEuropeNorth AmericaLatin AmericaMiddle East and Africa
About Contrive Datum Insights

Contrive Datum Insights is a global market intelligence and consulting firm working across investment, information technology, healthcare and manufacturing markets. Every market we publish is sized twice — once top-down from the leading players and once bottom-up from the addressable base — and validated by primary interview. More about CDI.

Asia Pacific
Kunjir Shyama Prestine, Sr. no. 174/1
Jagtap Diary Road, Pimple Saudagar
Pune 411017, India
+91 983 481 6757
United States
21C2 Lakeshore Dr.
Farmington, CT 06032
United States
+1 215 297 4078